Neurofibromatosis: genes and variants

Explore variant evidence for Neurofibromatosis across 4 analyzed proteins (NF1, NF2, MAP2K1, MAP2K2). Linked ClinVar records include 57 pathogenic or likely pathogenic variants, 1,336 variants of uncertain significance and 131 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Neurofibromatosis

Weakly linked (only a few uncertain records): ARID1B and NOTCH1.

ClinVar pathogenic and likely pathogenic variants linked to Neurofibromatosis

VariantPositionProtein partClinical label
NF2 L64P64FERMPathogenic / likely pathogenic (★★)
NF2 N220Y220FERMPathogenic / likely pathogenic (★★)
NF2 L517P517Pathogenic / likely pathogenic (★★)
NF1 M1I1Pathogenic / likely pathogenic (★★)
NF1 T59P59Pathogenic / likely pathogenic (★★)
NF1 I177K177Pathogenic / likely pathogenic (★★)
NF1 Q270P270Pathogenic / likely pathogenic (★★)
NF1 K395N395Pathogenic / likely pathogenic (★★)
NF1 L549R549Pathogenic / likely pathogenic (★★)
NF1 S574T574Pathogenic / likely pathogenic (★★)
NF1 V917G917Pathogenic / likely pathogenic (★★)
NF1 A1071P1071Pathogenic / likely pathogenic (★★)
NF1 L1104R1104Pathogenic / likely pathogenic (★★)
NF1 N1683K1683CRAL-TRIOPathogenic / likely pathogenic (★★)
NF1 G2397W2397Pathogenic / likely pathogenic (★★)
NF1 R1412T1412Ras-GAPPathogenic / likely pathogenic (★)
NF1 N1451K1451Ras-GAPPathogenic / likely pathogenic (★)
NF1 S2018I2018Pathogenic / likely pathogenic (★)
NF1 D1217Y1217Pathogenic / likely pathogenic (★)
NF1 D1217N1217Pathogenic / likely pathogenic (★)
NF1 R1412K1412Ras-GAPPathogenic / likely pathogenic (★)
NF1 M1461I1461Ras-GAPPathogenic / likely pathogenic (★)
NF1 S2018R2018Pathogenic / likely pathogenic (★)
NF1 N1154T1154Pathogenic / likely pathogenic (★)
NF1 L43R43Pathogenic / likely pathogenic (★)
NF1 S47F47Pathogenic / likely pathogenic (★)
NF1 V54D54Pathogenic / likely pathogenic (★)
NF1 I117N117Pathogenic / likely pathogenic (★)
NF1 L145P145Pathogenic / likely pathogenic (★)
NF1 D338N338Pathogenic / likely pathogenic (★)
NF1 A545E545Pathogenic / likely pathogenic (★)
NF1 M577R577Pathogenic / likely pathogenic (★)
NF1 W784G784Pathogenic / likely pathogenic (★)
NF1 R1000S1000Pathogenic / likely pathogenic (★)
NF1 N1156H1156Pathogenic / likely pathogenic (★)
NF1 T1191P1191Pathogenic / likely pathogenic (★)
NF1 T1199P1199Pathogenic / likely pathogenic (★)
NF1 G1277R1277Ras-GAPPathogenic / likely pathogenic (★)
NF1 S1279R1279Ras-GAPPathogenic / likely pathogenic (★)
NF1 L1446R1446Ras-GAPPathogenic / likely pathogenic (★)
NF1 E1458D1458Ras-GAPPathogenic / likely pathogenic (★)
NF1 F1536V1536Pathogenic / likely pathogenic (★)
NF1 A1610E1610CRAL-TRIOPathogenic / likely pathogenic (★)
NF1 D1644V1644CRAL-TRIOPathogenic / likely pathogenic (★)
NF1 T1646P1646CRAL-TRIOPathogenic / likely pathogenic (★)
NF1 D1849Y1849Pathogenic / likely pathogenic (★)
NF1 S1912R1912Pathogenic / likely pathogenic (★)
NF1 L1915R1915Pathogenic / likely pathogenic (★)
NF1 L1953V1953Pathogenic / likely pathogenic (★)
NF1 L1978P1978Pathogenic / likely pathogenic (★)
NF1 L2133V2133Pathogenic / likely pathogenic (★)
NF1 K2273T2273Pathogenic / likely pathogenic (★)
NF1 L2337P2337Pathogenic / likely pathogenic (★)
NF1 T2409R2409Pathogenic / likely pathogenic (★)
NF2 L360P360Pathogenic / likely pathogenic
NF2 L535P535Pathogenic / likely pathogenic
NF2 Q538P538Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Neurofibromatosis

VariantPositionProtein partClinical labelEvidence
NF1 G1277D1277Ras-GAPUncertain (★★)+6: 2 other pathogenic changes within 3 positions; G1277R at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.760

Which prediction tools work for Neurofibromatosis

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Neurofibromatosis

Frequently asked questions

Which genes have records linked to Neurofibromatosis?

This view contains 4 analyzed proteins: NF1, NF2, MAP2K1, MAP2K2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 57 pathogenic or likely pathogenic variants, 1,336 variants of uncertain significance and 131 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 1,637 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center